This HTML5 document contains 110 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n10http://dx.doi.org/10.1034/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q74528679
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel im Mai 2002 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована в травні 2002 scientific article published on 01 May 2002 artículu científicu espublizáu en mayu de 2002
p:P577
wds:Q74528679-0D111C88-475F-477F-8D18-6D93565F8D61
wdt:P577
2002-05-01T00:00:00Z
p:P2860
wds:Q74528679-BA5D81A2-4102-4DE1-9A7D-02B7A5E2FCD7 wds:Q74528679-BF93A2C6-80EF-4FD1-9FE8-5B78614609A7 wds:Q74528679-B82131CE-D73D-4975-A390-A2ECF68E6BDC wds:Q74528679-DFF3C6E4-21A3-4388-9DDA-0B3FFC32E925 wds:Q74528679-E72FC2A3-4AF1-481A-A305-387A6F2C8E4B wds:Q74528679-EE6CA028-E129-477F-B50F-ED91B98CC209 wds:Q74528679-D3DF9BCA-587A-4D0D-9EDD-B5D657886A1F wds:Q74528679-D41D6908-6FAD-4937-A0F8-3924649395BA wds:Q74528679-D8EC4271-4B75-481F-AC76-DC04DB82CC0D wds:Q74528679-DB20C8F2-8FF1-498E-880B-2C55DC71AB1A wds:Q74528679-FF66DEF6-0C94-42E7-9A6B-73C4C47B2F84 wds:Q74528679-EF5A888D-8C78-4818-8AD9-D8C704F92155 wds:Q74528679-F8D246FB-099A-4F4A-9C4F-527152E77EE9 wds:Q74528679-0CF8690B-C3BC-4611-AA07-CD48982A1A35 wds:Q74528679-4C330491-D573-495D-B070-78023A4C0BC2 wds:Q74528679-30B83D5D-7936-4495-A516-CE104D9585F7 wds:Q74528679-4128EFC9-CE6A-42F3-A538-EDBCFF16465B wds:Q74528679-63A2AAF6-FC7A-405F-9A17-7BFF74F4AFA3 wds:Q74528679-5DF8A25E-41ED-4A74-BE48-B798E9681F48 wds:Q74528679-5F06B0C1-368D-4F69-9F4B-424EC3E984F6 wds:Q74528679-60F3D6B5-0B9F-415A-A7ED-D64BAB96B47A wds:Q74528679-A0F2877A-78CC-4C20-96A8-F23DB45BA0C7 wds:Q74528679-A2522F51-F20B-40BD-BD15-8B51AE3800CF wds:Q74528679-AE6F60E1-E4AB-4BF1-B2A3-364B2B97188A wds:Q74528679-78D9A4C7-0EB4-4F88-A95E-904C8D48ED34 wds:Q74528679-8F3391BE-D33C-4F9F-BF49-647C5F766894 wds:Q74528679-92DBB4BD-A4CF-4DB6-A6BF-7A2AD167E4DA
wdt:P2860
wd:Q68829231 wd:Q68823724 wd:Q70909179 wd:Q67567811 wd:Q42597329 wd:Q68781360 wd:Q72102919 wd:Q34222528 wd:Q35703567 wd:Q67826090 wd:Q34245122 wd:Q34216833 wd:Q72664892 wd:Q39859200 wd:Q48239411 wd:Q40634968 wd:Q68037897 wd:Q34259334 wd:Q44388898 wd:Q34169256 wd:Q40634963 wd:Q34238663 wd:Q43648909 wd:Q73092649 wd:Q34261825 wd:Q28262183 wd:Q71742524
p:P2093
wds:Q74528679-6C69A801-B75D-4B39-B547-0831B264180C wds:Q74528679-73AF177E-6121-4199-BB1E-38912AF428D7 wds:Q74528679-A9997859-C40F-42A4-8C6F-17F26B04667A wds:Q74528679-2126886D-6282-45DF-A41B-FDFC7BABCB09 wds:Q74528679-B45D5965-2223-4D1E-8F0A-6A0876898880 wds:Q74528679-28D6A5FC-D518-4CA2-9356-C6F0D48417B0 wds:Q74528679-4F3A232E-A532-4FD9-B394-F78ACEB25E1C wds:Q74528679-B37B2F14-EE67-4DE0-A240-897CA7A341EF wds:Q74528679-433F901A-1BFA-4BAA-B47C-8D66930F81AB wds:Q74528679-D16B658F-6E15-4248-BDC6-0B94D0D33803
wdt:P2093
S Lindgren A Danielsson S Wallerstedt H Prytz R Wassmuth H Sandberg-Gertzen R Hultcrantz L Lööf F Depner R Olson
rdfs:label
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis
skos:prefLabel
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis
schema:name
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis
p:P1476
wds:Q74528679-54AA961A-B045-43D4-8910-A8BCAE307E35
wdt:P1476
HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis
p:P304
wds:Q74528679-40DC5B36-85BF-4BB6-BB84-CB82C879DE0D
wdt:P304
381-387
p:P31
wds:Q74528679-92C9CA5E-8BE1-4E51-A286-95529CDD8BD3
wdt:P31
wd:Q13442814
p:P921
wds:Q74528679-F5C23D39-2AFB-4386-8ABC-A1042B682DA9 wds:Q74528679-F9F291AA-B264-4D4A-9117-E43931A25D27
wdt:P921
wd:Q1072420 wd:Q928498
p:P698
wds:Q74528679-5260AD94-3C8F-4714-B017-818A6EC88C1E
wdtn:P698
n8:12144621
wdt:P698
12144621
p:P1433
wds:Q74528679-ED0EF7AB-42EC-4F51-8B6D-50282E6C1D65
wdt:P1433
wd:Q1573131
p:P433
wds:Q74528679-BC453EB6-10B9-4C3B-9383-E5536282FE6C
p:P478
wds:Q74528679-B094D5DD-11F2-4EB8-AFAA-BB27A6B607E1
wdt:P433
5
wdt:P478
59
p:P356
wds:Q74528679-623125E4-359D-4F35-90D7-7CCF6828E215
wdtn:P356
n10:J.1399-0039.2002.590504.X
wdt:P356
10.1034/J.1399-0039.2002.590504.X